Menu
Different types of feature have different effects on customer satisfaction – analysis by Quality expert, Noriaki Kano, is just as relevant now as it was
A friend in R&D was moaning about how his CEO was forever loading new projects into R&D. “It just fouls things up”, he said, “The
Although there are many tools and methodologies available to support R&D and much best practice, this is not readily available to those in industry. Assessing
When I was an R&D manager I often used to face the situation John Shave describes in his introduction when I was asked to approve
Procter & Gamble is a global consumer products company, the R&D activities are strongly driven by consumer needs and as a result the clock speed
Large R&D centric businesses have a huge asset in the vast experience that exists in their leading scientists – every trick in the book should
Pharmaceutical R&D is a complex, long and expensive task with a high project attrition rate. Only 5% of drug projects, that reach the stage of
Making up a “Risk Register” at the beginning of an R&D project obviously makes a lot of sense. However, risk assessment is not easy. There
Intuition can be very powerful, but when faced with novel situations our intuition is surprisingly easily led astray. There’s a whole body of work on
A good understanding of the R&D pipeline and portfolio is essential to reduce waste, duplication and poor use of valuable resources, says Joe de Sousa
Have your say / Follow us
R&D Today is the outreach site for the Research and Development Management Association, a charitable organisation that supports research, best practice and innovation. www.radma.net
© Copyright R&D Today
All rights reserved.